Particular catastrophic antiphospholipid syndrome, on the sole surgical site after breast reduction - Université de Lorraine Accéder directement au contenu
Article Dans Une Revue Journal of Plastic, Reconstructive and Aesthetic Surgery Année : 2013

Particular catastrophic antiphospholipid syndrome, on the sole surgical site after breast reduction

Résumé

A 20-year-old woman treated with vitamin K antagonist for antiphospholipid syndrome (APS) (pulmonary embolisms at age 15) was admitted for breast reduction after bridging therapy. At 2 days post-surgery haematomas appeared on the surgical site and anticoagulant therapy was withheld. She developed a skin and breast necrosis leading to the diagnosis of catastrophic APS. Despite medical treatment (anticoagulant therapy, corticosteroids and intravenous immunoglobulins) and surgery, necrosis continued. After 2 weeks of negative-pressure wound therapy (V.A.C.(®) Therapy™) the patient improved, mammary tissues were alive, well vascularised and budding. Breast reconstruction was then initiated. Artificial dermis graft (MatriDerm(®) 2 mm) was applied, and 3 weeks later the apposition of split-thickness skin graft on it. Six months later, results of the surgery were good and the patient was satisfied.
Fichier non déposé

Dates et versions

hal-01737703 , version 1 (19-03-2018)

Identifiants

Citer

Antoine de Runz, Stéphane Zuily, Jessica Gosset, Denis Wahl, Etienne Simon. Particular catastrophic antiphospholipid syndrome, on the sole surgical site after breast reduction. Journal of Plastic, Reconstructive and Aesthetic Surgery, 2013, 66 (11), pp.e321 - e324. ⟨10.1016/j.bjps.2013.04.037⟩. ⟨hal-01737703⟩
33 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More